VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 132 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,722,249 | -61.4% | 630,150 | -41.0% | 0.00% | -50.0% |
Q2 2023 | $7,044,418 | +4.7% | 1,068,956 | +7.9% | 0.00% | 0.0% |
Q1 2023 | $6,729,197 | +8.2% | 991,045 | +17.7% | 0.00% | 0.0% |
Q4 2022 | $6,221,000 | -31.0% | 842,151 | -7.7% | 0.00% | -33.3% |
Q3 2022 | $9,015,000 | +5.7% | 912,323 | +16.6% | 0.00% | 0.0% |
Q2 2022 | $8,527,000 | -5.6% | 782,425 | -2.0% | 0.00% | 0.0% |
Q1 2022 | $9,033,000 | -24.2% | 798,754 | +5.2% | 0.00% | 0.0% |
Q4 2021 | $11,915,000 | +84.6% | 759,281 | +101.6% | 0.00% | +50.0% |
Q3 2021 | $6,454,000 | -18.5% | 376,613 | +2.3% | 0.00% | 0.0% |
Q2 2021 | $7,919,000 | +56.8% | 368,197 | +9.5% | 0.00% | 0.0% |
Q1 2021 | $5,051,000 | -2.3% | 336,307 | -14.5% | 0.00% | 0.0% |
Q4 2020 | $5,168,000 | +16.3% | 393,306 | -14.5% | 0.00% | 0.0% |
Q3 2020 | $4,444,000 | +5.7% | 459,988 | +25.2% | 0.00% | 0.0% |
Q2 2020 | $4,204,000 | +9.1% | 367,418 | -1.3% | 0.00% | 0.0% |
Q1 2020 | $3,855,000 | -33.8% | 372,102 | +4.8% | 0.00% | 0.0% |
Q4 2019 | $5,826,000 | +21.9% | 355,032 | -1.3% | 0.00% | 0.0% |
Q3 2019 | $4,779,000 | -11.6% | 359,836 | -6.2% | 0.00% | 0.0% |
Q2 2019 | $5,404,000 | -35.3% | 383,491 | -15.5% | 0.00% | -50.0% |
Q1 2019 | $8,347,000 | -49.1% | 453,568 | -27.7% | 0.00% | -50.0% |
Q4 2018 | $16,398,000 | +254.5% | 627,599 | +211.4% | 0.01% | +300.0% |
Q3 2018 | $4,626,000 | +125.4% | 201,561 | +87.1% | 0.00% | +100.0% |
Q2 2018 | $2,052,000 | +23.8% | 107,726 | +9.5% | 0.00% | 0.0% |
Q1 2018 | $1,657,000 | +24.3% | 98,385 | +12.3% | 0.00% | 0.0% |
Q4 2017 | $1,333,000 | -15.5% | 87,646 | -0.6% | 0.00% | 0.0% |
Q3 2017 | $1,578,000 | +9.5% | 88,160 | -0.3% | 0.00% | 0.0% |
Q2 2017 | $1,441,000 | -25.0% | 88,436 | -34.1% | 0.00% | 0.0% |
Q4 2014 | $1,922,000 | +205.1% | 134,194 | +121.3% | 0.00% | – |
Q3 2014 | $630,000 | +10400.0% | 60,645 | +17227.1% | 0.00% | – |
Q2 2014 | $6,000 | -92.8% | 350 | -93.2% | 0.00% | – |
Q1 2014 | $83,000 | -82.5% | 5,130 | -86.6% | 0.00% | – |
Q4 2013 | $474,000 | -51.3% | 38,230 | -56.9% | 0.00% | -100.0% |
Q3 2013 | $974,000 | +5629.4% | 88,745 | +3939.4% | 0.00% | – |
Q2 2013 | $17,000 | – | 2,197 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |